# EVOLUTIONARY GENOMICS, INC.

EVOLUTIONARY GENOMICS, INC. is a company headquartered in Castle Rock, CO, United States.

## Company overview

- **Legal name:** EVOLUTIONARY GENOMICS, INC.
- **Former names in filing history:** Fona, Inc. (2010-09-23 to 2015-10-21)
- **Classification:** Company
- **Industry (SIC):** 8731 — Services-Commercial Physical & Biological Research
- **Headquarters:** Castle Rock, CO, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0000884363

## About

EVOLUTIONARY GENOMICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000884363, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2023-03-09, it reported net income of USD -1,934,967; total assets of USD 2,353,710 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$1.9M (USD -1,934,967)
- **Total assets:** $2.4M (USD 2,353,710)
- **Cash and equivalents:** $577,066 (USD 577,066)
- **Operating cash flow:** -$640,947 (USD -640,947)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$2.8M (USD -2,793,944)
- **Total assets:** $2.9M (USD 2,932,091)
- **Cash and equivalents:** $214,009 (USD 214,009)
- **Operating cash flow:** -$1.6M (USD -1,583,138)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $12,500 (USD 12,500)
- **Net income:** -$1.7M (USD -1,711,883)
- **Total assets:** $4.0M (USD 3,992,699)
- **Cash and equivalents:** $215,836 (USD 215,836)
- **Operating cash flow:** -$2.3M (USD -2,297,317)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $122,686 (USD 122,686)
- **Net income:** -$793,140 (USD -793,140)
- **Total assets:** $4.2M (USD 4,242,637)
- **Cash and equivalents:** $45,441 (USD 45,441)
- **Operating cash flow:** -$625,980 (USD -625,980)

## Recent SEC filings

- Form 10-K — filed 2023-03-09 — period 2022-12-31 — ANNUAL REPORT
- Form 10-Q — filed 2022-10-21 — period 2022-09-30 — QUARTERLY REPORT
- Form 10-Q — filed 2022-08-08 — period 2022-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2022-05-16 — period 2022-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2022-03-31 — period 2022-03-24 — CURRENT REPORT
- Form 10-K — filed 2022-03-22 — period 2021-12-31 — ANNUAL REPORT
- Form 10-Q — filed 2021-11-01 — period 2021-09-30 — QUARTERLY REPORT
- Form 10-Q — filed 2021-08-06 — period 2021-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2021-05-13 — period 2021-03-31 — QUARTERLY REPORT
- Form 10-K — filed 2021-03-31 — period 2020-12-31 — ANNUAL REPORT
- Form 10-Q — filed 2020-11-13 — period 2020-09-30 — QUARTERLY REPORT
- Form 10-Q — filed 2020-08-19 — period 2020-06-30 — QUARTERLY REPORT

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/evolutionary-genomics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology